Jenny Bulgarelli

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGenetically modified field crops and pasture
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jan 03, 2024
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.

Paolo A Ascierto, Milena Casula, Jenny Bulgarelli

|Mar 30, 2023
The Renewal of Cancer Immunotherapy.

Jenny Bulgarelli, Sara Pignatta, Massimiliano Petrini

|Jul 27, 2022
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.

Elena Pancisi, Anna Maria Granato, Emanuela Scarpi

|Jul 02, 2021
Effects of a Diet Based on Foods from Symbiotic Agriculture on the Gut Microbiota of Subjects at Risk for Metabolic Syndrome.

Silvia Turroni, Elisabetta Petracci, Valeria Edefonti

Pageof 1

Frequent Collaborators

3 joint publications

Laura Ridolfi

2 joint publications

Piotr Rutkowski

2 joint publications

Vanna Chiarion Sileni

2 joint publications

Ignacio Melero